Rheon Medical receives the 2020 Swiss Medtech award!

We are proud to announce that Rheon Medical, in partnership with Coat-X, has won the Swiss Medtech award 2020 for their eyeWatch system; the world’s first non-invasive pressure equalization system expected to revolutionize the treatment of glaucoma.

This coveted award was presented during the Swiss Medtech day on 21 September 2020 with over 500 conference participants and 27 applicants. The jurors evaluated the innovations in a two-stage process under the chairmanship of Professor Mirko Meboldt from ETH Zurich. Criteria included patient benefits, contribution to improvements in healthcare, pioneering technological spirit, and entrepreneurial performance.

The collaboration of Rheon Medical and Coat-X, who played a central role in the product development, was applauded by the industry and ESGTI is proud to be investing in further development of this technology as part of their Life Science pillar.

For the full press release see here: https://www.swiss-medtech.ch/sites/default/files/2020-07/200729_SwissMedtechAward_Nominees_E_final_0.pdf

About Swiss Medtech

Swiss Medtech represents more than 600 members in its role as industry association for Swiss medical technology. With 58,500 employees and a contribution of 13.5% to the positive trade balance, medical technology is an economically significant sector in Switzerland. Swiss Medtech advocates for conditions that enable the medtech industry to perform at peak capacity and provide first-class medical care.

More News

Capital Increase

ESGTI increased its capital by issuing 1,530,000 ordinary shares, resulting...

Capital Increase

ESGTI increased its capital by issuing a maximum number of...

ESG Conglomerate

ESG EKO AGRO Group is now positioned as an ESG...

Alternative Energy

ESG EKO AGRO AG acquired a significant stake in AltEnergis...

ESG investment portfolio

Wind Power

The group signed a binding (MoU) for the acquisition of...